Company Data
Prelude Therapeutics Incorporated
Ticker
PRLD
Current Price
$5.38 -3.93%
Market Cap
$429.3M
Price Target
Refer to Report
Volume
56.8K
52wk Range
$0.9807 - $6.83
Overview
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.